ACARIX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Acarix AB is engaged in the provision of medical devices for monitoring Coronary Artery Disease. It develops and commercializes diagnostic tests based on its technology platform CADScor System. The company was founded by Peter Boman Samuelsen, Samuel Schmidt, Weimin Rong and Claus Bo Vöge Christensen in 2009 and is headquartered in Malmo, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ACARIX has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company